SCHEMBL11575292

SCHEMBL11575292

COC(=O)OC1=C(C)NN=C(CCc2cccc(Cl)c2)C1c1cccc([N+](=O)[O-])c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.44
CYP3A4 P08684 6/20 0.44
CYP2C9 P11712 6/20 0.44
CYP2C19 P33261 6/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
MAPT P10636 5/20 0.44
LMNA P02545 5/20 0.44
CYP2D6 P10635 4/20 0.44
HIF1A Q16665 3/20 0.44
TSHR P16473 3/20 0.44
NFKB1 P19838 2/20 0.44
THPO P40225 2/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.44
GPR55 Q9Y2T6 1/20 0.44
PDE1C Q14123 1/20 0.44
CACNA1C Q13936 4/20 0.43
CACNA1F O60840 2/20 0.43
CACNA1D Q01668 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11253160 0.87 MAPT (0.55) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL11350210 0.78 CACNA1C (0.61) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL10352579 0.76 MEN1 (0.61) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL11324920 0.75 CACNA1F (0.53) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL11579185 0.75 CACNA1C (0.51) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL6425850 0.74 MEN1 (0.67) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL11364501 0.74 PDE1C (0.69) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL10974743 0.74 MEN1 (0.67) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL11330354 0.74 MEN1 (0.52) CYP1A2CYP3A4CYP2C9CYP2C19MEN1
SCHEMBL10912016 0.74 CACNA1C (0.60) CYP1A2CYP3A4CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0001108-A1 1,4-Dihydropyridazines, process for their preparation and their use in pharmaceuticals BAYER AG (DE) 1979-03-21 EP disclosed